Union Commerce Minister Piyush Goyal, speaking at BioAsia 2025, reaffirmed India’s commitment to collaborating with global stakeholders to address healthcare challenges. Highlighting India’s strengths in talent, cost advantages, and innovation, he emphasized the country’s transition from volume to value in pharma and biopharma.
Under PM Modi’s leadership, India is fostering international partnerships, advancing R&D, and implementing transformative healthcare initiatives such as PLI schemes, Genome India, and expanded public healthcare access. The government has also announced concessions for life-saving drugs in the recent budget.
Telangana CM A Revanth Reddy outlined his vision to make Hyderabad a global biosciences and life sciences hub. Union Minister G Kishan Reddy attended the valedictory session, urging investors to capitalize on India’s growing opportunities in healthcare and biotech.
